Galectin-8 Downmodulates TLR4 Activation and Impairs Bacterial Clearance in a Mouse Model of Pseudomonas aeruginosa Keratitis
Related Experiment Video
Updated: Aug 15, 2025

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
Published on: February 28, 2019
Abdulraouf Ramadan1, Zhiyi Cao1, Mujtaba Hassan2
1New England Eye Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, MA.
Abstract:
Pseudomonas aeruginosa provokes a painful, sight-threatening corneal infection. It progresses rapidly and is difficult to treat. In this study, using a mouse model of P. aeruginosa keratitis, we demonstrate the importance of a carbohydrate-binding protein, galectin-8 (Gal-8), in regulation of the innate immune response. First, using two distinct strains of P. aeruginosa, we established that Gal-8-/- mice are resistant to P. aeruginosa keratitis. In contrast, mice deficient in Gal-1, Gal-3, and Gal-9 were fully susceptible. Second, the addition of exogenous rGal-8 to LPS (TLR4 ligand)-stimulated bone marrow-derived macrophages suppressed 1) the activation of the NF-κB pathway, and 2) formation of the MD-2/TLR4 complex. Additionally, the expression level of reactive oxygen species was substantially higher in infected Gal-8-/- bone marrow neutrophils (BMNs) compared with the Gal-8+/+ BMNs, and the P. aeruginosa killing capacity of Gal-8-/- BMNs was considerably higher compared with that of Gal-8+/+ BMNs. In the bacterial killing assays, the addition of exogenous rGal-8 almost completely rescued the phenotype of Gal-8-/- BMNs. Finally, we demonstrate that a subconjunctival injection of a Gal-8 inhibitor markedly reduces the severity of infection in the mouse model of P. aeruginosa keratitis. These data lead us to conclude that Gal-8 downmodulates the innate immune response by suppressing activation of the TLR4 pathway and clearance of P. aeruginosa by neutrophils. These findings have broad implications for developing novel therapeutic strategies for treatment of conditions resulting from the hyperactive immune response both in ocular as well as nonocular tissues.
Insights
Galectin-8 (Gal-8) suppresses the innate immune response to Pseudomonas aeruginosa keratitis. Inhibiting Gal-8 enhances bacterial clearance and reduces infection severity, offering new therapeutic targets.
Area of Science:
- Immunology
- Microbiology
- Ophthalmology
Background:
- Pseudomonas aeruginosa causes severe keratitis, a difficult-to-treat corneal infection.
- The innate immune response plays a critical role in controlling P. aeruginosa infections.
Purpose of the Study:
- To investigate the role of galectin-8 (Gal-8) in regulating the innate immune response during P. aeruginosa keratitis.
- To evaluate Gal-8 as a potential therapeutic target for P. aeruginosa keratitis.
Main Methods:
- Utilized a mouse model of P. aeruginosa keratitis.
- Assessed the impact of Gal-8 deficiency on infection susceptibility and immune cell function.
- Investigated the effect of exogenous Gal-8 and a Gal-8 inhibitor on immune pathways and bacterial clearance.
Main Results:
- Gal-8 deficient mice were resistant to P. aeruginosa keratitis, unlike mice deficient in other galectins.
- Exogenous Gal-8 suppressed NF-κB activation and MD-2/TLR4 complex formation in macrophages.
- Gal-8 deficient neutrophils exhibited enhanced reactive oxygen species production and bacterial killing capacity, which was reversed by exogenous Gal-8.
- A Gal-8 inhibitor reduced infection severity in the mouse model.
Conclusions:
- Galectin-8 downmodulates the innate immune response by suppressing TLR4 pathway activation and neutrophil-mediated bacterial clearance.
- Targeting Gal-8 presents a promising therapeutic strategy for P. aeruginosa keratitis and potentially other hyperactive immune conditions.

